Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Share-based Compensation (2020 - 2025)

Sight Sciences (SGHT) has 6 years of Share-based Compensation data on record, last reported at -$3.8 million in Q4 2025.

  • For Q4 2025, Share-based Compensation fell 195.39% year-over-year to -$3.8 million; the TTM value through Dec 2025 reached $4.1 million, down 66.01%, while the annual FY2025 figure was $4.1 million, 75.99% down from the prior year.
  • Share-based Compensation reached -$3.8 million in Q4 2025 per SGHT's latest filing, down from $2.4 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $6.7 million in Q4 2023 and bottomed at -$3.8 million in Q4 2025.
  • Average Share-based Compensation over 5 years is $2.5 million, with a median of $2.4 million recorded in 2022.
  • Peak YoY movement for Share-based Compensation: skyrocketed 1050.91% in 2021, then plummeted 195.39% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $2.1 million in 2021, then soared by 162.27% to $5.5 million in 2022, then grew by 21.87% to $6.7 million in 2023, then plummeted by 40.73% to $3.9 million in 2024, then tumbled by 195.39% to -$3.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Share-based Compensation were -$3.8 million in Q4 2025, $2.4 million in Q3 2025, and $1.2 million in Q2 2025.